Funding Sources

Sponsor | % of overall organisation’s income

Industry related income (80,95%)

Hoffmann – La Roche Ltd | 23,76%

Novartis | 8,60% 

Prilenia Neurotherapeutics Ltd | 17,41%

PTC Therapeutics | 11,45%

Uniqure | 7,23%

Wave Life Sciences | 12,50%

Non-Industry related income (19,05%)

Revenue from 2022 | 2,89%

HSG Clinical Research Inc | 10,98%

Huntington Liga | 5,18%

Find the full document here:

🎄 This Holiday Season, Make a Difference!

Join our Teaming initiative and support the European Huntington Association in bringing hope and help to families affected by Huntington’s disease. 💙 Together, we get stronger.